Korean Journal of Ophthalmology10.3341/kjo.2015.29.3.1602015293160The Association between Choroidal Thickness Variations and Response to Intravitreal Bevacizumab in Central Serous ChorioretinopathyDong Yoon Kim, Soo Geun Joe, Sung Jae Yang, Joo Yong Lee, June-Gone Kim, Young Hee Yoon,,
Journal of Clinical Medicine10.3390/jcm11123375202211123375Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous ChorioretinopathyYoo-Ri Chung, Su Jeong Lee, Ji Hun Song
10.21203/rs.2.15383/v12019Prognostic factor for the response to intravitreal bevacizumab treatment in central serous chorioretinopathy patients.Chunghyun Lee, Yu Jeong Kim, Soo Geun Joe, Sungjae Yang,
Japanese Journal of Ophthalmology10.1007/s10384-012-0138-32012563245-249Intravitreal bevacizumab for iatrogenic choroidal neovascularization due to laser photocoagulation in central serous chorioretinopathyYoko Nomura, Ryo Obata, Yasuo Yanagi,,
European Journal of Ophthalmology10.5301/ejo.50000362011223488-491Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathyJoseph Pikkel, Shimon Rumelt,,
Acta Ophthalmologica Scandinavica10.1111/j.1600-0420.2007.01062_3402.x2007850-0Photodynamic therapy with Verteporfin combined with intravitreal injection of Bevacizumab for central serous chorioretinopathyM MAIER,
Acta Ophthalmologica10.1111/j.1755-3768.2016.0249201694The long-term effect of intravitreal bevacizumab injection in central serous chorioretinopathyS.J. Mun, C. Choi, J.G. Jeong,
Journal of the Korean Ophthalmological Society10.3341/jkos.2012.53.9.135220125391352Intravitreal Bevacizumab Injection for Choroidal Neovascularization Secondary to Laser Photocoagulation for Central Serous ChorioretinopathyJong Hyun Jung, Kun Moon, Kwang Soo Kim, Yu Cheol Kim,,
Optometry - Journal of the American Optometric Association10.1016/j.optm.2010.04.0912010818383-384The effectiveness of intravitreal injection of bevacizumab for management of central serous chorioretinopathyMarc D. Myers,
Acta Ophthalmologica10.1111/j.1755-3768.2013.f053.x2013910-0Effect of intravitreal bevacizumab for chronic, recurrent, or atypical central serous chorioretinopathyJH SONG, YR CHUNG, MH KIM, HM LEW,